Developments in the scientific understanding of lupus

Arthritis Research and Therapy

Volumn 10, Issue 5, 2008, Pages

  Ardoin, Stacy P ^a   Pisetsky, David S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYTOKINE; DNA ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; AUTOANTIGEN;

ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ATHEROSCLEROSIS; B LYMPHOCYTE; CYTOKINE PRODUCTION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NONHUMAN; REVIEW; RISK FACTOR; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; VASCULITIS; ANIMAL; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 54149096930     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2488     Document Type: Review

References (52)

1. International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) Harley JB Alarcón-Riquelme ME Criswell LA Jacob CO Kimberly RP Moser KL Tsao BP Vyse TJ Langefeld CD Nath SK Guthridge JM Cobb BL Mirel DB Marion MC Williams AH Divers J Wang W Frank SG Namjou B Gabriel SB Lee AT Gregersen PK Behrens TW Taylor KE Fernando M Zidovetzki R Gaffney PM Edberg JC Rioux JD Ojwang JO et al.: Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci Nat Genet 2008, 40:204-210. 10.1038/ng.81 18204446
2. Hom G Graham RR Modrek B Taylor KE Ortmann W Garnier S Lee AT Chung SA Ferreira RC Pant PV Ballinger DG Kosoy R Demirci FY Kamboh MI Kao AH Tian C Gunnarsson I Bengtsson AA Rantapää-Dahlqvist S Petri M Manzi S Seldin MF Rönnblom L Syvänen AC Criswell LA Gregersen PK Behrens TW Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX N Engl J Med 2008, 358:900-909. 10.1056/ NEJMoa0707865 18204098
3. Lauwerys BR Wakeland EK Genetics of lupus nephritis Lupus 2005, 14:2-12. 10.1191/0961203305lu2052oa 15732281
4. Liu K Li QZ Yu Y Liang C Subramanian S Zeng Z Wang HW Xie C Zhou XJ Mohan C Wakeland EK Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis Genes Immun 2007, 8:634-645. 10.1038/ sj.gene.6364426 17728789
5. Ballestar E Esteller M Richardson BC The epigenetic face of systemic lupus erythematosus J Immunol 2006, 176:7143-7147. 16751355
6. Harley JB Harley IT Guthridge JM James JA The curiously suspicious: A role for Epstein-Barr virus in lupus Lupus 2006, 15:768-777. 10.1177/ 0961203306070009 17153849
7. McCarty GA Rice JR Bembe ML Pisetsky DS Independent expression of autoantibodies in systemic lupus erythematosus J Rheumatol 1982, 9:691-695. 6983576
8. Hahn BH Antibodies to DNA N Engl J Med 1998, 338:1359-1368. 10.1056/ NEJM199805073381906 9571257
9. Arbuckle MR McClain MT Rubertone MV Scofield RH Dennis GJ James JA Harley JB Development of autoantibodies before the clinical onset of systemic lupus erythematosus N Engl J Med 2003, 349:1526-1533. 10.1056/ NEJMoa021933 14561795
10. Bianchi ME DAMPs, PAMPs and alarmins: All we need to know about danger J Leukoc Biol 2007, 81:1-5. 10.1189/jlb.0306164 17032697
11. Ishii KJ Akira S Innate immune recognition of nucleic acids: Beyond toll-like receptors Int J Cancer 2005, 117:517-523. 10.1002/ijc.21402 16080197
12. Ishii KJ Akira S Innate immune recognition of, and regulation by, DNA Trends Immunol 2006, 27:525-532. 10.1016/j.it.2006.09.002 16979939
13. Kelly KM Zhuang H Nacionales DC Scumpia PO Lyons R Akaogi J Lee P Williams B Yamamoto M Akira S Satoh M Reeves WH 'Endogenous adjuvant' activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60 Arthritis Rheum 2006, 54:1557-1567. 10.1002/art.21819 16645989
14. Munoz LE van Bavel C Franz S Berden J Herrmann M Vlag van der J Apoptosis in the pathogenesis of systemic lupus erythematosus Lupus 2008, 17:371-375. 10.1177/0961203308089990 18490410
15. Gaipl US Munoz LE Grossmayer G Lauber K Franz S Sarter K Voll RE Winkler T Kuhn A Kalden J Kern P Herrmann M Clearance deficiency and systemic lupus erythematosus (SLE) J Autoimmun 2007, 28:114-121. 10.1016/ j.jaut.2007.02.005 17368845
16. Yurasov S Wardemann H Hammersen J Tsuiji M Meffre E Pascual V Nussenzweig MC Defective B cell tolerance checkpoints in systemic lupus erythematosus J Exp Med 2005, 201:703-711. 2212839 15738055 10.1084/ jem.20042251
17. Jacobi AM Odendahl M Reiter K Bruns A Burmester GR Radbruch A Valet G Lipsky PE Dorner T Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus Arthritis Rheum 2003, 48:1332-1342. 10.1002/art.10949 12746906
18. Jacobi AM Reiter K Mackay M Aranow C Hiepe F Radbruch A Hansen A Burmester GR Diamond B Lipsky PE Dörner T Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95 Arthritis Rheum 2008, 58:1762-1773. 10.1002/art.23498 18512812
19. Cappione A 3rd Anolik JH Pugh-Bernard A Barnard J Dutcher P Silverman G Sanz I Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus J Clin Invest 2005, 115:3205-3216. 1242189 16211091 10.1172/JCI24179
20. Ramanujam M Davidson A The current status of targeting BAFF/BLyS for autoimmune diseases Arthritis Res Ther 2004, 6:197-202. 546289 15380033 10.1186/ar1222
21. Fritsch RD Shen X Illei GG Yarboro CH Prussin C Hathcock KS Hodes RJ Lipsky PE Abnormal differentiation of memory T cells in systemic lupus erythematosus Arthritis Rheum 2006, 54:2184-2197. 10.1002/art.21943 16802356
22. Valencia X Yarboro C Illei G Lipsky PE Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus J Immunol 2007, 178:2579-2588. 17277168
23. Yan B Ye S Chen G Kuang M Shen N Chen S Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells Arthritis Rheum 2008, 58:801-812. 10.1002/art.23268 18311820
24. Crispin JC Kyttaris VC Juang YT Tsokos GC How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype Trends Immunol 2008, 29:110-115. 10.1016/j.it.2007.12.003 18249583
25. Lu L Kaliyaperumal A Boumpas DT Datta SK Major peptide autoepitopes for nucleosome-specific T cells of human lupus J Clin Invest 1999, 104:345-355. 408421 10430616 10.1172/JCI6801
26. Baechler EC Batliwalla FM Karypis G Gaffney PM Ortmann WA Espe KJ Shark KB Grande WJ Hughes KM Kapur V Gregersen PK Behrens TW Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc Natl Acad Sci USA 2003, 100:2610-2615. 151388 12604793 10.1073/pnas.0337679100
27. Bennett L Palucka AK Arce E Cantrell V Borvak J Banchereau J Pascual V Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J Exp Med 2003, 197:711-723. 2193846 12642603 10.1084/jem.20021553
28. Kirou KA Lee C George S Louca K Papagiannis IG Peterson MG Ly N Woodward RN Fry KE Lau AY Prentice JG Wohlgemuth JG Crow MK Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus Arthritis Rheum 2004, 50:3958-3967. 10.1002/art.20798 15593221
29. Nacionales DC Kelly-Scumpia KM Lee PY Weinstein JS Lyons R Sobel E Satoh M Reeves WH Deficiency of the type I interferon receptor protects mice from experimental lupus Arthritis Rheum 2007, 56:3770-3783. 10.1002/ art.23023 17968932
30. Ronnblom L Eloranta ML Alm GV The type I interferon system in systemic lupus erythematosus Arthritis Rheum 2006, 54:408-420. 10.1002/art.21571 16447217
31. Lovgren T Eloranta ML Bave U Alm GV Ronnblom L Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG Arthritis Rheum 2004, 50:1861-1872. 10.1002/ art.20254 15188363
32. Means TK Latz E Hayashi F Murali MR Golenbock DT Luster AD Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 J Clin Invest 2005, 115:407-417. 544604 15668740
33. Vollmer J Tluk S Schmitz C Hamm S Jurk M Forsbach A Akira S Kelly KM Reeves WH Bauer S Krieg AM Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 J Exp Med 2005, 202:1575-1585. 2213330 16330816 10.1084/ jem.20051696
34. Tian J Avalos AM Mao SY Chen B Senthil K Wu H Parroche P Drabic S Golenbock D Sirois C Hua J An LL Audoly L La Rosa G Bierhaus A Naworth P Marshak-Rothstein A Crow MK Fitzgerald KA Latz E Kiener PA Coyle AJ Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 2007, 8:487-496. 10.1038/ni1457 17417641
35. Dong L Ito S Ishii KJ Klinman DM Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupusprone NZB × NZW mice Arthritis Rheum 2005, 52:651-658. 10.1002/art.20810 15692999
36. Barrat FJ Meeker T Chan JH Guiducci C Coffman RL Treatment of lupusprone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms Eur J Immunol 2007, 37:3582-3586. 10.1002/eji.200737815 18034431
37. Christensen SR Shupe J Nickerson K Kashgarian M Flavell RA Shlomchik MJ Toll-like receptor 7 and TLR9 dictate autoanti-body specificity and have opposing inflammatory and regulatory roles in a murine model of lupus Immunity 2006, 25:417-428. 10.1016/j.immuni.2006.07.013 16973389
38. Halicka HD Bedner E Darzynkiewicz Z Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis Exp Cell Res 2000, 260:248-256. 10.1006/excr.2000.5027 11035919
39. Foster MH Kelley VR Lupus nephritis: Update on pathogenesis and disease mechanisms Semin Nephrol 1999, 19:173-181. 10192250
40. Couzi L Merville P Deminiere C Moreau JF Combe C Pellegrin JL Viallard JF Blanco P Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis Arthritis Rheum 2007, 56:2362-2370. 10.1002/art.22654 17599764
41. Rovin BH Song H Birmingham DJ Hebert LA Yu CY Nagaraja HN Urine chemokines as biomarkers of human systemic lupus erythematosus activity J Am Soc Nephrol 2005, 16:467-473. 10.1681/ASN.2004080658 15601744
42. Kowal C DeGiorgio LA Nakaoka T Hetherington H Huerta PT Diamond B Volpe BT Cognition and immunity; antibody impairs memory Immunity 2004, 21:179-188. 10.1016/j.immuni.2004.07.011 15308099
43. Hanly JG Robichaud J Fisk JD Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus J Rheumatol 2006, 33:1553-1558. 16881112
44. Eber T Chapman J Shoenfeld Y Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: Myth or reality? Lupus 2005, 14:571-575. 10.1191/0961203305lu2150rr 16175927
45. Katzav A Solodeev I Brodsky O Chapman J Pick CG Blank M Zhang W Reichlin M Shoenfeld Y Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system Arthritis Rheum 2007, 56:938-948. 10.1002/art.22419 17328071
46. Iikuni N Okamoto H Yoshio T Sato E Kamitsuji S Iwamoto T Momohara S Taniguchi A Yamanaka H Minota S Kamatani N Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus Ann Rheum Dis 2006, 65:253-256. 10.1136/ ard.2005.041640 16410530
47. Fragoso-Loyo H Richaud-Patin Y Orozco-Narvaez A Davila-Maldonado L Atisha-Fregoso Y Llorente L Sanchez-Guerrero J Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus Arthritis Rheum 2007, 56:1242-1250. 10.1002/art.22451 17393453
48. Bruce IN 'Not only...but also': Factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus Rheumatology (Oxford) 2005, 44:1492-1502. 10.1093/rheumatology/kei142 16234277
49. Rajagopalan S Somers EC Brook RD Kehrer C Pfenninger D Lewis E Chakrabarti A Richardson BC Shelden E McCune WJ Kaplan MJ Endothelial cell apoptosis in systemic lupus erythematosus: A common pathway for abnormal vascular function and thrombosis propensity Blood 2004, 103:3677-3683. 10.1182/blood-2003-09-3198 14726373
50. Moonen JR de Leeuw K van Seijen XJ Kallenberg CG van Luyn MJ Bijl M Harmsen MC Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus Arthritis Res Ther 2007, 9:R84. 2206388 17764548 10.1186/ar2283
51. Merrill JT Erkan D Buyon JP Challenges in bringing the bench to bedside in drug development for SLE Nat Rev Drug Discov 2004, 3:1036-1046. 10.1038/nrd1577 15573102
52. Kyburz D Brentano F Gay S Mode of action of hydroxychloroquine in RA-evidence of an inhibitory effect on toll-like receptor signaling Nat Clin Pract Rheumatol 2006, 2:458-459. 10.1038/ncprheum0292 16951696